Infinity Discovery Inc - Cambridge, Massachusetts 02139

Infinity Discovery Inc is categorized under Commercial Biotechnical Research in Cambridge, MA .

Business Name: Infinity Discovery Inc
Contact Person: Steve Holtzman
Address: 780 Memorial Drive, Cambridge, Massachusetts 02139
Phone Number: (617) 453-1000
Website Address: infi.com
Annual Revenue (USD): $20.000.000 to $49.9999.999
Founding Year: 2006
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Commercial Biotechnical Research
SIC Code: 8731
NAICS Code: 541711
Share This Business:
Related Businesses: Mindsjungle Inc - Cambridge, MA 02139
Babyboost Inc - Cambridge, MA 02139
Visolis Inc - Cambridge, MA 02139
Volvox Biologic Inc - Cambridge, MA 02139
Manus Biosynthesis - Cambridge, MA 02139
Human Metabolome Technologies - Cambridge, MA 02139
Epi Zyme Inc - Cambridge, MA 02139
Mersana Therapeutics Inc - Cambridge, MA 02139
Dna Medicine Institute Inc - Cambridge, MA 02139
Galenea Corp - Cambridge, MA 02139
Bluebird Bio Inc - Cambridge, MA 02139
Ariad Corp - Cambridge, MA 02139
Alantos Pharmaceuticals Inc - Cambridge, MA 02139
Rana Therapeutics Inc - Cambridge, MA 02139
Warp Drive Bio LLC - Cambridge, MA 02139

The company Infinity Discovery Inc provides B2B services in the form of Commercial Biotechnical Research from its single location in Massachusetts. 1 to 4 employees work for Infinity Discovery Inc, and the business now earns $20.000.000 to $49.9999.999 per annum.

Infinity Discovery Inc was launched in 2006 and is classified under SIC code and category 8731 , and NAICS number and grouping 541711 . To contact Infinity Discovery Inc, please call Steve Holtzman with the phone number (617) 453-1000 or visit its single location at 780 Memorial Drive in Cambridge, Massachusetts 02139.

The location of the single location can also be found using the coordinates 42.359,-71.115429. Read more details about this business on the webpage infi.com or follow the company’s social media accounts, on Twitter and on Facebook.